DCLK1 and pancreatitis: Dclk1+ cells in the normal pancreas harbor the potential function to initiate premalignant lesions when the oncogenic Kras mutation is introduced together with inflammatory stimuli such as caerulein-induced pancreatitis in vivo (Westphalen et al., 2016).